Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tapinarof for Cutaneous Lupus Erythematosus

NCT06661213 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT06661213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06661213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tapinarof for Cutaneous Lupus Erythematosus
Lead sponsor
Northwestern University
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
April 3, 2025
Completion date
November 30, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous lupus erythematosus